Adverse events of the new generation of active bone conduction hearing implants (BCI602 and OSI200): a MAUDE database analysis

This is the authors' abstract. We don't add key points for this paper.

Background A new generation of active transcutaneous bone conduction implants (BCI) are available since 2019 and literature comprising technical and medical complications is sparse. The aim of this investigation is to report on medical device reports submitted to FDA MAUDE database to identify adverse events (AEs) in patients implant with novel active BCIs.